5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.84▲ | 1.82▲ | 1.82▲ | 1.79▲ | 1.80▲ |
MA10 | 1.82▲ | 1.81▲ | 1.81▲ | 1.80▲ | 1.90▼ |
MA20 | 1.80▲ | 1.79▲ | 1.81▲ | 1.80▲ | 1.74▲ |
MA50 | 1.87▼ | 1.91▼ | 1.94▼ | 1.89▼ | 3.89▼ |
MA100 | 1.95▼ | 1.93▼ | 1.88▼ | 1.73▲ | 9.97▼ |
MA200 | 1.88▼ | 1.74▲ | 1.70▲ | 2.49▼ | 21.12▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.014▲ | 0.013▲ | 0.010▲ | 0.005▲ | 0.208▲ |
RSI | 50.095▲ | 50.301▲ | 49.437▼ | 51.150▲ | 41.655▼ |
STOCH | 77.535 | 63.403 | 63.705 | 41.622 | 30.552 |
WILL %R | -23.077▲ | -17.647▲ | -17.647▲ | -40.625 | -48.539 |
CCI | 47.875 | 86.920 | 76.793 | 45.363 | -29.517 |
Wednesday, May 15, 2024 10:53 AM
Sonnet BioTherapeutics (NASDAQ:SONN) just reported results for the second quarter of 2024.Sonnet BioTherapeutics reported earnings per share of 7 cents. This was below the analyst estimate for EPS of ...
|
Tuesday, May 14, 2024 01:41 PM
Published Phase 1 data of SON-1010 in Frontiers in Immunology demonstrating the safety and tolerability of the F H AB-derived Interleukin 12 in healthy volunteersAnnounced early safety data from the c ...
|
Tuesday, May 14, 2024 09:15 AM
Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the three months and six months ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 1.86 | 1.86 | 1.84 | 1.84 | 14,016 |
15/05/24 | 1.83 | 1.90 | 1.7194 | 1.79 | 7,552 |
14/05/24 | 1.89 | 1.8999 | 1.7601 | 1.81 | 29,230 |
13/05/24 | 1.79 | 1.81 | 1.78 | 1.79 | 38,361 |
10/05/24 | 1.83 | 1.88 | 1.65 | 1.70 | 27,223 |
09/05/24 | 1.8169 | 1.8169 | 1.7531 | 1.8104 | 7,574 |
08/05/24 | 1.805 | 1.805 | 1.76 | 1.76 | 6,447 |
07/05/24 | 1.91 | 1.91 | 1.77 | 1.79 | 9,295 |
06/05/24 | 1.90 | 1.9499 | 1.86 | 1.86 | 14,765 |
03/05/24 | 1.97 | 1.97 | 1.809 | 1.8604 | 7,518 |
|
|
||||
|
|
||||
|
|